e-learning
resources
ERJ
2004
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene
Brasch F., Griese M., Tredano M., Johnen G., Ochs M., Rieger C., Mulugeta S., Muller K.M., Bahuau M., Beers M.F.
Source:
Eur Respir J 2004; 24: 30-39
Journal Issue:
July
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Brasch F., Griese M., Tredano M., Johnen G., Ochs M., Rieger C., Mulugeta S., Muller K.M., Bahuau M., Beers M.F.. Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene. Eur Respir J 2004; 24: 30-39
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumonias
Source: Eur Respir J 2007; 29: 134-137
Year: 2007
Surfactant proteins in interstitial pneumonia
Source: Annual Congress 2005 - Lung-specific serum markers for interstitial lung diseases
Year: 2005
Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias
Source: Eur Respir J 2011; 37: 1119-1127
Year: 2011
Role of
ABCA3
in paediatric interstitial lung disease associated with surfactant protein C gene mutations
Source: Annual Congress 2009 - Genetics of lung diseases
Year: 2009
Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals
Source: Eur Respir J 2011; 37: 791-799
Year: 2011
A novel non-BRICHOS surfactant protein C mutation causing infantile interstitial lung disease is associated with reduced mature SP-C level
Source: International Congress 2018 – Orphan diseases in children
Year: 2018
MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Serum surfactant protein D (SP-D) and annual decline of diffusion capacity are prognostic factors for combined pulmonary fibrosis with emphysema (CPFE) in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases
Year: 2013
A new mutation of surfactant protein C gene causing severe respiratory insufficiency and pulmonary fibrosis
Source: Annual Congress 2012 - Paediatric bronchology
Year: 2012
Pertechnegas lung clearance in different forms of interstitial lung disease
Source: Eur Respir J 2002; 19: 31-36
Year: 2002
Difference in the dynamic state between SP-A and SP-D in the IPF lung
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Lysozyme level and activity are decreased in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and potentially contribute to increased susceptibility to pulmonary infection
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006
Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP)
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Interstitial fibrosis with a nodule
Source: Annual Congress 2007 - Thoracic Oncology Grand Round: an interactive session
Year: 2007
Serum surfactant protein D may predict the effect of pirfenidone in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Interstitial lung disease in a child heterozygous for the 1549C?GAA (121ins2) mutation of surfactant protein B
Source: Eur Respir J 2011; 38: 985-987
Year: 2011
Familial interstitial lung disease and ABCA3 gene Gly964Asp mutation
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
SFTPA mutations in interstitial lung disease (ILD) and lung cancer
Source: International Congress 2017 – Rare diseases
Year: 2017
Aquoaporin-1 expression in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Rare interstitial lung diseases (LAM, LHC, alveolar proteinosis, eosinophilic pneumonias)
Source: ERS Course 2016
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept